Targeted natural killer cell–based adoptive immunotherapy for the treatment of patients with NSCLC after radiochemotherapy: a randomized phase II clinical trial
- Submitting institution
-
Nottingham Trent University
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 72 - 1369993
- Type
- D - Journal article
- DOI
-
10.1158/1078-0432.ccr-20-1141
- Title of journal
- Clinical Cancer Research
- Article number
- -
- First page
- 5368
- Volume
- 26
- Issue
- 20
- ISSN
- 1078-0432
- Open access status
- Compliant
- Month of publication
- September
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
24
- Research group(s)
-
A - Centre for Health Ageing and Understanding Disease
- Citation count
- 1
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Submitted member of staff Pockley made substantial contributions to the research: a. Pockley contributed to data curation [confirmed by the published author contribution statement contained within the output] and made a substantial contribution to the conception and design of the study and to the analysis and interpretation of the reported data [confirmed in writing by corresponding author, Multhoff], and; b. Pockley helped draft the output by writing - review and editing [confirmed by the published author contribution statement contained within the output] and critiqued the paper for important intellectual content [confirmed in writing by corresponding author, Multhoff].
- Non-English
- No
- English abstract
- -